Momenta Phamaceuticals, Inc. (MNTA) Misses Q4 FFO by 7c
MNTA Hot Sheet
EPS Growth %: -108.8%Financial Fact:
Total operating expenses: 29.52M
Today's EPS Names:
TARO, BRLI, TLB, More
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q4 FFO of $0.20, $0.07 worse than the analyst estimate of $0.27.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Lowe's (LOW) Beats Q1 Views Amid Lagging Seasonal Demand; Issues Light FY12 Earnings Outlook
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
